Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice

Evidence and guidelines are becoming increasingly clear about imbalance between the risks and benefits of inhaled corticosteroids (ICSs) in patients with COPD. While selected patients may benefit from ICS-containing regimens, ICSs are often inappropriately prescribed with – according to Belgian mark...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Chron Obstruct Pulmon Dis
Autors principals: Cataldo, Didier, Derom, Eric, Liistro, Giuseppe, Marchand, Eric, Ninane, Vincent, Peché, Rudi, Slabbynck, Hans, Vincken, Walter, Janssens, Wim
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2018
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6039066/
https://ncbi.nlm.nih.gov/pubmed/30013336
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S164259
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars